- FTSE 100 down 0.1%, FTSE 250 off 0.3%
Nov 10 (Reuters) - UK's blue-chip FTSE 100 index fell on Thursday, as miners and oil giants tracked losses in commodity prices, although a strong performance by drugmaker AstraZeneca following an upbeat forecast helped cap losses ahead of key U.S. inflation data.
The large-cap FTSE 100 dipped 0.1% by 0822 GMT. The mid-cap FTSE 250 shed 0.3%.
Energy firms and miners fell 1% and 1.3%, respectively, tracking prices of oil and metals that were hit by a stronger U.S. dollar.
Shares of AstraZeneca jumped 1.5% after the drugmaker raised its full-year adjusted earnings forecast, helped by sales of its roster of cancer drugs. The wider pharmaceuticals sector rose 1.2%.
The U.S. consumer prices data is likely to show an easing in the monthly and yearly core numbers for October to 0.5% and 6.5%, respectively, according to a Reuters poll.
WH Smith climbed 4.1% after the company reinstated dividends and posted an annual profit, supported by a post-pandemic travel rebound.
Reporting by Johann M Cherian in Bengaluru; Editing by Sherry Jacob-Phillips